Reversible leucopenia related to olanzapineMEISSNER, W; SCHMIDT, T; KUPSCH, A et al.Movement disorders. 1999, Vol 14, Num 5, pp 872-873, issn 0885-3185Article

Early relapse of psychotic symptoms after an initial response to olanzapine. CommentaryKOSTAKOGLU, A. E; REZAKI, M; GÖGÜS, A et al.Acta psychiatrica Scandinavica. 1999, Vol 100, Num 4, pp 312-315, issn 0001-690XArticle

Olanzapine-induced psychotic mania in bipolar schizo-affective disorderBENAZZI, F.European psychiatry. 1999, Vol 14, Num 7, pp 410-411, issn 0924-9338Article

Neuroleptic malignant syndrome associated with olanzapineJOHNSON, V; BRUXNER, G.Australian and New Zealand journal of psychiatry. 1998, Vol 32, Num 6, pp 884-886, issn 0004-8674Article

Olanzapine-induced glucose dysregulationBETTINGER, T. L; MENDELSON, S. C; DORSON, P. G et al.The Annals of pharmacotherapy. 2000, Vol 34, Num 7-8, pp 865-867, issn 1060-0280Article

Olanzapine-induced weight gainGUPTA, S; DRONEY, T; AL-SAMARRAI, S et al.Annals of clinical psychiatry. 1998, Vol 10, Num 1, issn 1040-1237, p. 39Article

Efficacy of atypical antipsychotics in mood disordersYATHAM, Lakshmi N.Journal of clinical psychopharmacology. 2003, Vol 23, Num 3, pp S9-S14, issn 0271-0749, SUP1Conference Paper

Diabète sous neuroleptiques = Diabetes under neuroleptic agentsLa Revue Prescrire. 2001, Vol 21, Num 223, issn 0247-7750, p. 834Article

Six-month outcomes for patients who switched to Olanzapine treatmentNOORDSY, Douglas L; O'KEEFE, Christopher; MUESER, Kim T et al.Psychiatric services (Washington, D.C.). 2001, Vol 52, Num 4, pp 501-507, issn 1075-2730Article

Impact clinique des neuroleptiques atypiques : étude prospective sur 6 mois en milieu hospitalier de patients traités par rispéridone ou olanzapine = Clinical impact of atypical antipsychotics: prospective 6-month study of inpatients treated by risperidone or olanzapineHAMEL, B; COURTET, P; VERGNES, C et al.Thérapie (Paris). 2001, Vol 56, Num 6, pp 645-652, issn 0040-5957, 8 p.Article

Disposition of olanzapine in Chinese schizophrenic patientsLANE, H. Y; LIU, H. C; VANDENBERG, C. M et al.International journal of clinical pharmacology and therapeutics. 2000, Vol 38, Num 10, pp 482-485, issn 0946-1965Article

Olanzapine response in psychotic depressionROTHSCHILD, A. J; BATES, K. S; BOEHRINGER, K. L et al.The Journal of clinical psychiatry. 1999, Vol 60, Num 2, pp 116-118, issn 0160-6689Article

Olanzapine overdose mimicking opioid intoxicationO'MALLEY, G. F; SEIFERT, S; HEARD, K et al.Annals of emergency medicine. 1999, Vol 34, Num 2, pp 279-281, issn 0196-0644Article

Characterization of olanzapine-induced weight gain in ratsGOUDIE, Andrew J; SMITH, Judith A; HALFORD, Jason C. G et al.Journal of psychopharmacology (Oxford). 2002, Vol 16, Num 4, pp 291-296, issn 0269-8811, 6 p.Article

L'olanzapine (Zyprexa) = OlanzapineSAHEBJAM, M; SERRA, E.La Presse médicale (1983). 2000, Vol 29, Num 38, pp 2106-2108, issn 0755-4982Article

Prescription hospitalière de la rispéridone et de l'olanzapine : enquête et recommandations = Prescription of risperidone and olanzapine in hospital units : investigation and recommandationsHAMEL, B; COURTET, P; VERGNES, C et al.Journal de pharmacie clinique (Paris). 2000, Vol 19, Num 3, pp 187-193, issn 0291-1981Article

Olanzapine versus placebo in the treatment of acute maniaTOHEN, M; SANGER, T. M; GREANEY, M. G et al.The American journal of psychiatry. 1999, Vol 156, Num 5, pp 702-709, issn 0002-953XArticle

A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patientsPASSIK, Steven D; KIRSH, Kenneth L; THEOBALD, Dale E et al.Journal of pain and symptom management. 2003, Vol 25, Num 5, pp 485-489, issn 0885-3924, 5 p.Article

Impact clinique des neuroleptiques atypiques : étude prospective sur 6 mois en milieu hospitalier de patients traités par rispéridone ou olanzapine = Clinical impact of atypical antipsychotics: prospective 6-month study of inpatients treated by risperidone or olanzapineHAMEL, B; COURTET, P; VERGNES, C et al.Thérapie (Paris). 2001, Vol 56, Num 6, pp 645-652, issn 0040-5957Article

The effectiveness of olanzapine in treatment-refractory schizophrenia when Patients are nonresponsive to or unable to tolerate clozapineDOSSENBACH, Martin R. K; BEUZEN, Jean-Noel; GRUNDY, Starr Lee et al.Clinical therapeutics. 2000, Vol 22, Num 9, pp 1021-1034, issn 0149-2918Article

Bulles induites par une intoxication neuroleptique aiguë = Bullae induced by acute neuroleptic intoxicationBOYE, T; CARSUZAA, F.Annales de dermatologie et de vénéréologie. 2000, Vol 127, Num 10, issn 0151-9638, p. 865Article

Olanzapine increases weight and serum triglyceride levelsOSSER, D. N; NAJARIAN, D. M; DUFRESNE, R. L et al.The Journal of clinical psychiatry. 1999, Vol 60, Num 11, pp 767-770, issn 0160-6689Conference Paper

Accidents vasculaires cérébraux et décès sous olanzapine = Cerebrovascular adverse events and death under olanzapineLa Revue Prescrire. 2004, Vol 24, Num 250, issn 0247-7750, p. 349Article

Serum ghrelin concentrations in patients receiving olanzapine or risperidoneTOGO, Takashi; HASEGAWA, Koichi; MIURA, Satoshi et al.Psychopharmacologia. 2004, Vol 172, Num 2, pp 230-232, issn 0033-3158, 3 p.Article

Antipsychotic-induced weight gain: Bipolar disorder and leptinMCINTYRE, Roger S; MANCINI, Deborah A; BASILE, Vincenzo S et al.Journal of clinical psychopharmacology. 2003, Vol 23, Num 4, pp 323-327, issn 0271-0749, 5 p.Article